- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.45 Å
- Oligo State
- homo-tetramer
- Ligands
- 12 x ZN: ZINC ION(Non-covalent)
- 4 x 9XS: (2~{S},3~{R},4~{S})-2-[(2~{S},3~{R})-1,3-bis(oxidanyl)-1-oxidanylidene-butan-2-yl]-4-[(3~{S},5~{S})-5-[(3-carboxyphenyl)carbamoyl]pyrrolidin-3-yl]sulfanyl-3-methyl-3,4-dihydro-2~{H}-pyrrole-5-carboxylic acid(Non-covalent)
9XS.4: 16 residues within 4Å:- Chain A: Y.13, W.19, H.86, H.88, A.89, D.90, H.91, F.126, I.130, H.162, S.187, S.189, P.191, H.227
- Ligands: ZN.1, ZN.2
14 PLIP interactions:14 interactions with chain A- Hydrophobic interactions: A:F.126, A:I.130, A:P.191
- Hydrogen bonds: A:Y.13, A:S.187, A:S.189, A:S.189
- Salt bridges: A:H.86, A:H.86, A:H.88, A:H.91, A:H.162, A:H.162, A:H.227
9XS.10: 16 residues within 4Å:- Chain B: Y.13, W.19, H.86, H.88, A.89, D.90, H.91, F.126, I.130, H.162, S.187, S.189, P.191, H.227
- Ligands: ZN.7, ZN.8
14 PLIP interactions:14 interactions with chain B- Hydrophobic interactions: B:F.126, B:I.130, B:P.191
- Hydrogen bonds: B:Y.13, B:S.187, B:S.189, B:S.189
- Salt bridges: B:H.86, B:H.86, B:H.88, B:H.91, B:H.162, B:H.162, B:H.227
9XS.16: 16 residues within 4Å:- Chain C: Y.13, W.19, H.86, H.88, A.89, D.90, H.91, F.126, I.130, H.162, S.187, S.189, P.191, H.227
- Ligands: ZN.13, ZN.14
14 PLIP interactions:14 interactions with chain C- Hydrophobic interactions: C:F.126, C:I.130, C:P.191
- Hydrogen bonds: C:Y.13, C:S.187, C:S.189, C:S.189
- Salt bridges: C:H.86, C:H.86, C:H.88, C:H.91, C:H.162, C:H.162, C:H.227
9XS.22: 16 residues within 4Å:- Chain D: Y.13, W.19, H.86, H.88, A.89, D.90, H.91, F.126, I.130, H.162, S.187, S.189, P.191, H.227
- Ligands: ZN.19, ZN.20
14 PLIP interactions:14 interactions with chain D- Hydrophobic interactions: D:F.126, D:I.130, D:P.191
- Hydrogen bonds: D:Y.13, D:S.187, D:S.189, D:S.189
- Salt bridges: D:H.86, D:H.86, D:H.88, D:H.91, D:H.162, D:H.162, D:H.227
- 8 x SO4: SULFATE ION(Non-functional Binders)
SO4.5: 4 residues within 4Å:- Chain A: R.139, V.146, I.147, T.148
8 PLIP interactions:8 interactions with chain A- Hydrogen bonds: A:T.148, A:T.148, A:T.148
- Water bridges: A:R.139, A:R.139, A:R.139, A:R.139
- Salt bridges: A:R.139
SO4.6: 6 residues within 4Å:- Chain A: R.175, A.239, R.240, A.241, G.242, A.243
7 PLIP interactions:7 interactions with chain A- Hydrogen bonds: A:A.239, A:G.242
- Water bridges: A:R.175, A:R.175, A:A.241, A:A.241
- Salt bridges: A:R.175
SO4.11: 4 residues within 4Å:- Chain B: R.139, V.146, I.147, T.148
8 PLIP interactions:8 interactions with chain B- Hydrogen bonds: B:T.148, B:T.148, B:T.148
- Water bridges: B:R.139, B:R.139, B:R.139, B:R.139
- Salt bridges: B:R.139
SO4.12: 6 residues within 4Å:- Chain B: R.175, A.239, R.240, A.241, G.242, A.243
7 PLIP interactions:7 interactions with chain B- Hydrogen bonds: B:A.239, B:G.242
- Water bridges: B:R.175, B:R.175, B:A.241, B:A.241
- Salt bridges: B:R.175
SO4.17: 4 residues within 4Å:- Chain C: R.139, V.146, I.147, T.148
8 PLIP interactions:8 interactions with chain C- Hydrogen bonds: C:T.148, C:T.148, C:T.148
- Water bridges: C:R.139, C:R.139, C:R.139, C:R.139
- Salt bridges: C:R.139
SO4.18: 6 residues within 4Å:- Chain C: R.175, A.239, R.240, A.241, G.242, A.243
7 PLIP interactions:7 interactions with chain C- Hydrogen bonds: C:A.239, C:G.242
- Water bridges: C:R.175, C:R.175, C:A.241, C:A.241
- Salt bridges: C:R.175
SO4.23: 4 residues within 4Å:- Chain D: R.139, V.146, I.147, T.148
8 PLIP interactions:8 interactions with chain D- Hydrogen bonds: D:T.148, D:T.148, D:T.148
- Water bridges: D:R.139, D:R.139, D:R.139, D:R.139
- Salt bridges: D:R.139
SO4.24: 6 residues within 4Å:- Chain D: R.175, A.239, R.240, A.241, G.242, A.243
7 PLIP interactions:7 interactions with chain D- Hydrogen bonds: D:A.239, D:G.242
- Water bridges: D:R.175, D:R.175, D:A.241, D:A.241
- Salt bridges: D:R.175
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Twidale, R.M. et al., Crystallography and QM/MM Simulations Identify Preferential Binding of Hydrolyzed Carbapenem and Penem Antibiotics to the L1 Metallo-beta-Lactamase in the Imine Form. J.Chem.Inf.Model. (2021)
- Release Date
- 2021-10-13
- Peptides
- Metallo-beta-lactamase L1: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.45 Å
- Oligo State
- homo-tetramer
- Ligands
- 12 x ZN: ZINC ION(Non-covalent)
- 4 x 9XS: (2~{S},3~{R},4~{S})-2-[(2~{S},3~{R})-1,3-bis(oxidanyl)-1-oxidanylidene-butan-2-yl]-4-[(3~{S},5~{S})-5-[(3-carboxyphenyl)carbamoyl]pyrrolidin-3-yl]sulfanyl-3-methyl-3,4-dihydro-2~{H}-pyrrole-5-carboxylic acid(Non-covalent)
- 8 x SO4: SULFATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Twidale, R.M. et al., Crystallography and QM/MM Simulations Identify Preferential Binding of Hydrolyzed Carbapenem and Penem Antibiotics to the L1 Metallo-beta-Lactamase in the Imine Form. J.Chem.Inf.Model. (2021)
- Release Date
- 2021-10-13
- Peptides
- Metallo-beta-lactamase L1: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A